For the quarter ending 2025-09-28, PFE had -$301M decrease in cash & cash equivalents over the period. $4,001M in free cash flow.
| Cash Flow | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-12-31 |
|---|---|---|---|---|
| Net income from continuing operations before allocation to noncontrolling interests | 3,551 | 2,903 | 2,973 | 411 |
| Depreciation and amortization | 1,662 | 1,625 | 1,618 | 1,791 |
| Asset write-offs and impairments | 366 | 154 | 344 | 3,162 |
| Deferred taxes | -765 | -272 | -663 | -396 |
| Share-based compensation expense | 201 | 203 | 170 | 177 |
| Benefit plan contributions in excess of expense/income | 84 | 105 | 229 | -454 |
| Inventory write-offs and related charges associated with covid-19 products | - | - | - | 0 |
| Other adjustments, net | 292 | 101 | -40 | 1,805 |
| Trade accounts receivable | - | - | - | 109 |
| Inventories | - | - | - | 854 |
| Other assets | - | - | - | -3,380 |
| Trade accounts payable | - | - | - | -1,023 |
| Other liabilities | - | - | - | -3,115 |
| Other tax accounts, net | - | - | - | -1,345 |
| Other changes in assets and liabilities, net of acquisitions and divestitures | 36 | 4,989 | -4,073 | - |
| Net cash provided by/(used in) operating activities | 4,603 | -582 | 2,335 | 6,721 |
| Purchases of property, plant and equipment | 602 | 618 | 564 | 917 |
| Purchases of short-term investments | 4,223 | 3,262 | 2,823 | 6,176 |
| Proceeds from redemptions/sales of short-term investments | 2,736 | 6,545 | 3,955 | 1,498 |
| Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less | 583 | -1,184 | 3,852 | -487 |
| Purchases of long-term investments | 129 | -48 | 134 | 105 |
| Proceeds from redemptions/sales of long-term investments | 359 | 63 | 82 | 29 |
| Proceeds from sale of investment in haleon | 0 | 0 | 6,311 | 3,549 |
| Acquisitions of businesses, net of cash acquired | - | - | - | 0 |
| Dividend received from the consumer healthcare jv | - | - | - | 0 |
| Other investing activities, net | -14 | 12 | -313 | - |
| Net cash provided by/(used in) investing activities | -2,430 | 3,951 | 3,274 | -1,623 |
| Proceeds from short-term borrowings | 0 | 0 | 0 | 732 |
| Payments on short-term borrowings | 0 | 151 | 2,048 | 3,452 |
| Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less | 6 | -517 | -386 | 0 |
| Proceeds from issuance of long-term debt | 0 | 3,687 | - | 0 |
| Payments on long-term debt | 0 | 3,750 | 0 | 0 |
| Purchases of common stock | - | - | - | 0 |
| Cash dividends paid | 2,444 | 2,445 | 2,437 | 2,380 |
| Other financing activities, net | -38 | -21 | -356 | -14 |
| Net cash provided by/(used in) financing activities | -2,477 | -3,196 | -5,227 | -5,114 |
| Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents | 2 | 41 | -7 | -29 |
| Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents | -301 | 213 | 375 | -45 |
| Cash and cash equivalents at beginning of period | 1,694 | 1,481 | 1,107 | 1,152 |
| Cash and cash equivalents at end of period | 1,394 | 1,694 | 1,481 | 1,107 |
PFIZER INC (PFE)
PFIZER INC (PFE)